(Date:11/19/2009)...people would like to be able to charge their cell ...not too often. A recent discovery made by UC San D... supercapacitors that could do just this. , In ...ters , Prabhakar Bandaru, a professor in the UCSD ..., along with graduate student Mark Hoefer, have fo...
(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Mate...extract, responds to a press release issued on Nov...rian company for making false and self-serving sta...nces. ,, Dr. Hidvegi stated from his office in...hat research on Avemar does not apply to AveULTRA,...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 ...or in biotechnology for diabetes therapy, and a pr...ices to food, supplement, biotechnology and pharma... Tuesday,s Annual Meeting of Shareholders. ,, A...d (Nasdaq: SPEX ) elected the following members t...
(Date:11/19/2009)..., MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeu...patient in a randomized Phase 2B study of AEG35156...velopment for multiple oncology indications. ,,...se 2 Study of the X-Linked Inhibitor of Apoptosis ...h High-dose Cytarabine and Idarubicin in AML Follo...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2... 13 Hollingsworth & Vose,Company (H&V), a leading...,today introduced its HVision(TM) technology platf...he development and commercialization of,breakthrou...hanced R&D process focused on,creating a new gener...benchmarks in the industry," said Val Hollingswort...
... Equity Research, Inc.,(Scimitar) issues a review ...I), entitled, "Injecting Confidence to the Viprine...ains Do Move". This review is available at our we...ogical Technologies, Inc. (NTII) is a biotechnolog... developing central nervous system,related drug ca...
...Corporation (OTC,Bulletin Board: KDUS.OB) announce...ded September 30, 2007. Revenues were $0 for the ...006. Net income for the third quarter of 2007 was ...he same period in 2006. Basic net income per,share...he same period in,2006. Revenues were $100,000 fo...
Other Biology Technology:H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products 2Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc. 2Cadus Reports Third Quarter 2007 Results 2Cadus Reports Third Quarter 2007 Results 3Cadus Reports Third Quarter 2007 Results 4...handful of very special mice, scientists have disc...emical signature implicated in the development of ...box" of opportunity and possibility, study authors...Comprehensive Cancer Center bred a type of mouse t...he mouse first goes through a pre-leukemic stage m...
...s been looking for a "Fontaine de Jouvence" foreve...where to be found, we are making,progress; in worm...,humans had the unexpected effect of prolonging th...e medications slows the rate of aging in,roundworm...ty School of,Medicine in St. Louis. When exposed t...
...d class of drugs that keep the HIV-virus infection...tentially lethal heart rhythm disturbances in some...igation appears in the current edition of The Lan...HIV Program of Hennepin County Medical Center, Min..., and University of Wisconsin, Madison, the Mayo C...
Other Biology News:Genome-wide mouse study yields link to human leukemia 2Genome-wide mouse study yields link to human leukemia 3Research on Worms Yields Clues on Aging 2HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs 2HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs 3Diethyl pyrocarbonate from Research Organics, Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Permeabilization Solution, 5X from CHEMICON
Cytofix/Cytoperm Kit from BD Biosciences Pharmingen
Biology Products: